Published in Immunobiology on August 01, 1998
Pathogenesis of systemic lupus erythematosus. J Clin Pathol (2003) 2.93
Genetic susceptibility to systemic lupus erythematosus in the genomic era. Nat Rev Rheumatol (2010) 2.18
Infections of people with complement deficiencies and patients who have undergone splenectomy. Clin Microbiol Rev (2010) 1.70
Heavily isotype-dependent protective activities of human antibodies against vaccinia virus extracellular virion antigen B5. J Virol (2009) 1.69
Follicular dendritic cells control engulfment of apoptotic bodies by secreting Mfge8. J Exp Med (2008) 1.65
Unraveling the genetics of systemic lupus erythematosus. Springer Semin Immunopathol (2006) 1.64
Chronic inflammation: a failure of resolution? Int J Exp Pathol (2007) 1.54
Cancer immunosuppression and autoimmune disease: beyond immunosuppressive networks for tumour immunity. Immunology (2006) 1.54
Complement C4 inhibits systemic autoimmunity through a mechanism independent of complement receptors CR1 and CR2. J Exp Med (2000) 1.51
Complement protein C1q-mediated neuroprotection is correlated with regulation of neuronal gene and microRNA expression. J Neurosci (2011) 1.41
Complement C1q is hydroxylated by collagen prolyl 4 hydroxylase and is sensitive to off-target inhibition by prolyl hydroxylase domain inhibitors that stabilize hypoxia-inducible factor. Kidney Int (2017) 1.38
Complement C1q reduces early atherosclerosis in low-density lipoprotein receptor-deficient mice. Am J Pathol (2007) 1.36
C1q deficiency leads to the defective suppression of IFN-alpha in response to nucleoprotein containing immune complexes. J Immunol (2010) 1.34
Overview of complement activation and regulation. Semin Nephrol (2013) 1.26
The consequences of apoptosis in autoimmunity. J Autoimmun (2008) 1.24
Genetics of SLE in mice. Springer Semin Immunopathol (2006) 1.11
The type I interferon system in the etiopathogenesis of autoimmune diseases. Ups J Med Sci (2011) 1.10
Differential gene expression in the salivary gland during development and onset of xerostomia in Sjögren's syndrome-like disease of the C57BL/6.NOD-Aec1Aec2 mouse. Arthritis Res Ther (2009) 1.07
Complement, c1q, and c1q-related molecules regulate macrophage polarization. Front Immunol (2014) 1.06
Current topics in human SLE genetics. Springer Semin Immunopathol (2006) 1.06
Reduced expression of CD44 on monocytes and neutrophils in systemic lupus erythematosus: relations with apoptotic neutrophils and disease activity. Ann Rheum Dis (2001) 1.00
Evidence that a C1q/C1qR system regulates monocyte-derived dendritic cell differentiation at the interface of innate and acquired immunity. Innate Immun (2009) 1.00
Emerging and Novel Functions of Complement Protein C1q. Front Immunol (2015) 0.99
C1q receptors. Clin Exp Immunol (2000) 0.98
The role of complement in the acquired immune response. Immunology (2000) 0.98
C1q complement component and -antibodies reflect SLE activity and kidney involvement. Clin Rheumatol (2005) 0.97
Evaluation of C1q genomic region in minority racial groups of lupus. Genes Immun (2009) 0.97
Increased urinary levels of the leukocyte adhesion molecules ICAM-1 and VCAM-1 in human lupus nephritis with advanced renal histological changes: preliminary findings. Clin Exp Nephrol (2010) 0.95
The C1q family of proteins: insights into the emerging non-traditional functions. Front Immunol (2012) 0.95
Breaking immunological tolerance in systemic lupus erythematosus. Front Immunol (2014) 0.94
Complement protein C1q bound to apoptotic cells suppresses human macrophage and dendritic cell-mediated Th17 and Th1 T cell subset proliferation. J Leukoc Biol (2014) 0.94
GWAS and drug targets. BMC Genomics (2014) 0.93
Common silent mutations in all types of hereditary complement C1q deficiencies. Immunogenetics (2005) 0.93
B cells in autoimmunity. Proc Natl Acad Sci U S A (2000) 0.92
New Zealand mixed mice: a genetic systemic lupus erythematosus model for assessing environmental effects. Environ Health Perspect (1999) 0.92
Cell surface expression and function of the macromolecular c1 complex on the surface of human monocytes. Front Immunol (2012) 0.91
Infections and systemic lupus erythematosus. Eur J Clin Microbiol Infect Dis (2014) 0.90
Genetic risk factors of systemic lupus erythematosus in the Malaysian population: a minireview. Clin Dev Immunol (2011) 0.87
Contribution of Defective PS Recognition and Efferocytosis to Chronic Inflammation and Autoimmunity. Front Immunol (2014) 0.86
Anti-mannose binding lectin antibodies in sera of Japanese patients with systemic lupus erythematosus. Clin Exp Immunol (2004) 0.85
Infection in systemic lupus erythematosus: friend or foe? Int J Clin Rheumtol (2010) 0.85
Complement protein C1q promotes macrophage anti-inflammatory M2-like polarization during the clearance of atherogenic lipoproteins. Inflamm Res (2014) 0.82
Systemic Lupus Erythematosus and Deficiencies of Early Components of the Complement Classical Pathway. Front Immunol (2016) 0.82
Monocyte Expressed Macromolecular C1 and C1q Receptors as Molecular Sensors of Danger: Implications in SLE. Front Immunol (2014) 0.82
Genetics of SLE: functional relevance for monocytes/macrophages in disease. Clin Dev Immunol (2012) 0.81
Identification of novel coding mutation in C1qA gene in an African-American pedigree with lupus and C1q deficiency. Lupus (2012) 0.80
Do follicular dendritic cells regulate lupus-specific B cells? Mol Immunol (2014) 0.80
Association of reactive oxygen and nitrogen intermediate and complement levels with apoptosis of peripheral blood mononuclear cells in lupus patients. Arthritis Rheum (2007) 0.80
Collectin liver 1 and collectin kidney 1 and other complement-associated pattern recognition molecules in systemic lupus erythematosus. Clin Exp Immunol (2015) 0.79
Monocytosis and accelerated activation of lymphocytes in C1q-deficient autoimmune-prone mice. Immunology (2004) 0.79
Breakdown of Immune Tolerance in Systemic Lupus Erythematosus by Dendritic Cells. J Immunol Res (2016) 0.78
Apoptotic cell responses in the splenic marginal zone: a paradigm for immunologic reactions to apoptotic antigens with implications for autoimmunity. Immunol Rev (2016) 0.78
The autoreactivity of B cells in hereditary angioedema due to C1 inhibitor deficiency. Clin Exp Immunol (2012) 0.78
SLE-associated risk factors affect DC function. Immunol Rev (2016) 0.78
Lack of evidence of a specific role for C4A gene deficiency in determining disease susceptibility among C4-deficient patients with systemic lupus erythematosus (SLE). Clin Exp Immunol (2001) 0.78
CTLA-4 polymorphisms and systemic lupus erythematosus: a comprehensive meta-analysis. Genet Test Mol Biomarkers (2013) 0.77
Role of Natural Autoantibodies and Natural IgM Anti-Leucocyte Autoantibodies in Health and Disease. Front Immunol (2016) 0.77
Natural IgM and the Development of B Cell-Mediated Autoimmune Diseases. Crit Rev Immunol (2016) 0.77
Partial construction of apoptotic pathway in PBMC obtained from active SLE patients and the significance of plasma TNF-alpha on this pathway. Clin Rheumatol (2006) 0.76
The identification of a novel splicing mutation in C1qB in a Japanese family with C1q deficiency: a case report. Pediatr Rheumatol Online J (2013) 0.75
Fundamental role of C1q in autoimmunity and inflammation. Immunol Res (2015) 0.75
Potential serum and urine biomarkers in patients with lupus nephritis and the unsolved problems. Open Access Rheumatol (2016) 0.75
The contribution of the programmed cell death machinery in innate immune cells to lupus nephritis. Clin Immunol (2016) 0.75
C1q as an autocrine and paracrine regulator of cellular functions. Mol Immunol (2016) 0.75
C1q Deficiency and Neuropsychiatric Systemic Lupus Erythematosus. Front Immunol (2016) 0.75
Molecular characterization of the complement C1q, C2 and C4 genes in Brazilian patients with juvenile systemic lupus erythematosus. Clinics (Sao Paulo) (2015) 0.75
Renal disease associated with inherited disorders of the complement system. Pediatr Nephrol (2008) 0.75
The effect of education, assessment and a standardised prescription on postoperative pain management. The value of clinical audit in the establishment of acute pain services. Anaesthesia (1998) 4.72
Serum amyloid P component controls chromatin degradation and prevents antinuclear autoimmunity. Nat Med (1999) 3.88
A hierarchical role for classical pathway complement proteins in the clearance of apoptotic cells in vivo. J Exp Med (2000) 3.65
Systemic lupus erythematosus, complement deficiency, and apoptosis. Adv Immunol (2000) 2.59
Complement facilitates early prion pathogenesis. Nat Med (2001) 2.30
Temporary depletion of complement component C3 or genetic deficiency of C1q significantly delays onset of scrapie. Nat Med (2001) 1.99
Prevention of C5 activation ameliorates spontaneous and experimental glomerulonephritis in factor H-deficient mice. Proc Natl Acad Sci U S A (2006) 1.87
Targeted deletion of the CD59 gene causes spontaneous intravascular hemolysis and hemoglobinuria. Blood (2001) 1.65
Hereditary C1q deficiency and systemic lupus erythematosus. QJM (1994) 1.47
Ultraviolet-radiation-induced keratinocyte apoptosis in C1q-deficient mice. J Invest Dermatol (2001) 1.44
Buerger's disease and protein S deficiency: successful treatment with prostacyclin. Clin Exp Rheumatol (1995) 1.40
Accelerated nephrotoxic nephritis is exacerbated in C1q-deficient mice. J Immunol (2001) 1.36
MRL/Mp CD4+,CD25- T cells show reduced sensitivity to suppression by CD4+,CD25+ regulatory T cells in vitro: a novel defect of T cell regulation in systemic lupus erythematosus. Arthritis Rheum (2005) 1.32
A survey of acute pain services in the United Kingdom. BMJ (1995) 1.27
Multiple lupus susceptibility loci map to chromosome 1 in BXSB mice. J Immunol (1998) 1.25
Complement deficiencies in humans and animals: links to autoimmunity. Autoimmunity (2006) 1.22
Non-invasive imaging in the diagnosis and management of Takayasu's arteritis. Ann Rheum Dis (2004) 1.21
Diabetes and rhabdomyolysis. A rare complication of a common disease. BMJ (1993) 1.20
Macrophages from patients with SLE and rheumatoid arthritis have defective adhesion in vitro, while only SLE macrophages have impaired uptake of apoptotic cells. Ann Rheum Dis (2005) 1.19
Expression of Fcgamma and complement receptors on peripheral blood monocytes in systemic lupus erythematosus and rheumatoid arthritis. Rheumatology (Oxford) (2004) 1.17
Reconstitution of the complement function in C1q-deficient (C1qa-/-) mice with wild-type bone marrow cells. J Immunol (2001) 1.14
Fc gamma RIIa polymorphism in systemic lupus erythematosus (SLE): no association with disease. Clin Exp Immunol (1996) 1.13
A targeted disruption of the murine complement factor B gene resulting in loss of expression of three genes in close proximity, factor B, C2, and D17H6S45. J Biol Chem (1998) 1.13
Clinical significance of IgA anticardiolipin and anti-beta2-GP1 antibodies in patients with systemic lupus erythematosus and primary antiphospholipid syndrome. Clin Rheumatol (2005) 1.11
Induction of decay-accelerating factor by cytokines or the membrane-attack complex protects vascular endothelial cells against complement deposition. Blood (1999) 1.10
Meningococcal septicaemia in a C6-deficient patient and effects of plasma transfusion on lipopolysaccharide release. Lancet (1992) 1.06
Continual low-level activation of the classical complement pathway. J Exp Med (2001) 1.06
T cell-dependent immune response in C1q-deficient mice: defective interferon gamma production by antigen-specific T cells. J Exp Med (1998) 1.05
Role of the classical pathway of complement activation in experimentally induced polymicrobial peritonitis. Infect Immun (2001) 1.05
Overrepresentation of the Fcgamma receptor type IIA R131/R131 genotype in caucasoid systemic lupus erythematosus patients with autoantibodies to C1q and glomerulonephritis. Arthritis Rheum (1999) 1.05
Both Fcgamma and complement receptors mediate transfer of immune complexes from erythrocytes to human macrophages under physiological flow conditions in vitro. Clin Exp Immunol (2006) 1.05
Identification of thiopurine methyltransferase (TPMT) polymorphisms cannot predict myelosuppression in systemic lupus erythematosus patients taking azathioprine. Rheumatology (Oxford) (1999) 1.05
Complement deficiency and autoimmunity. Ann N Y Acad Sci (1997) 1.03
Hereditary complement factor I deficiency. QJM (1994) 1.02
Hereditary disorders of the red cell membrane skeleton. Trends Genet (1989) 1.01
Identification of chromosome intervals from 129 and C57BL/6 mouse strains linked to the development of systemic lupus erythematosus. Genes Immun (2006) 1.01
Cutting edge: C1q protects against the development of glomerulonephritis independently of C3 activation. J Immunol (1999) 1.01
Chromosome 7 long arm deletion in myeloid disorders: a narrow breakpoint region in 7q22 defined by molecular mapping. Blood (1989) 1.00
Genomic organization of human complement component C3. Genomics (1990) 1.00
Erythrocyte complement receptor type 1 and interactions between immune complexes, neutrophils, and endothelium. J Immunol (1994) 0.96
[Liver involvement in systemic lupus erythematosus]. Recenti Prog Med (1993) 0.95
IFN-gamma up-regulates expression of the complement components C3 and C4 by stabilization of mRNA. J Immunol (1996) 0.94
Complement contributes to protective immunity against reinfection by Plasmodium chabaudi chabaudi parasites. Infect Immun (2001) 0.94
Molecular characterization of leukocyte adhesion deficiency in six patients. Eur J Immunol (1995) 0.93
Altered major histocompatibility complex class II peptide loading in H2-O-deficient mice. Eur J Immunol (2000) 0.92
The rate of loss of CR1 from ageing erythrocytes in vivo in normal subjects and SLE patients: no correlation with structural or numerical polymorphisms. Clin Exp Immunol (1988) 0.92
Immune complex processing in C1q-deficient mice. Clin Exp Immunol (2001) 0.90
C3 nephritic factor and SLE: report of four cases and review of the literature. QJM (1994) 0.90
Antral Campylobacter pylori colonization, ABO blood group, and secretor status. Gastroenterol Clin Biol (1989) 0.89
Identification of intervals on chromosomes 1, 3, and 13 linked to the development of lupus in BXSB mice. Arthritis Rheum (2000) 0.89
Autoantibodies to the collagenous region of C1q occur in three strains of lupus-prone mice. Clin Exp Immunol (1996) 0.89
The molecular basis of hereditary complement factor I deficiency. J Clin Invest (1996) 0.88
Peripheral blood lymphocytes in SLE--hyperexpression of CD154 on T and B lymphocytes and increased number of double negative T cells. J Autoimmun (1998) 0.88
Organ-specific contribution to circulating C7 levels by the bone marrow and liver in humans. Eur J Immunol (1996) 0.87
Combinations of low concentrations of cytokines and acute agonists synergize in increasing the permeability of endothelial monolayers. Clin Exp Immunol (1993) 0.87
Antibody-mediated glomerulonephritis in mice: the role of endotoxin, complement and genetic background. Clin Exp Immunol (2003) 0.87
Significance of anticardiolipin and anti-beta(2)-glycoprotein I antibodies in lupus nephritis. Rheumatology (Oxford) (2000) 0.87
Bilateral gluteal abscesses as a unique manifestation of fusobacterium septicaemia. Rheumatology (Oxford) (2000) 0.87
GABA(A) receptor epsilon-subunit may confer benzodiazepine insensitivity to the caudal aspect of the nucleus tractus solitarii of the rat. J Physiol (2001) 0.86
Further data supporting linkage between cystic fibrosis and the met oncogene and haplotype analysis with met and pJ3.11. Am J Hum Genet (1986) 0.85
The complement system. Curr Biol (1998) 0.85
Expression of vascular cell adhesion molecule-1 by vascular endothelial cells in immune and nonimmune inflammatory reactions in the skin. J Immunol (1997) 0.85
Complement and immune complexes. Res Immunol (1996) 0.84
Shiga toxin-2 results in renal tubular injury but not thrombotic microangiopathy in heterozygous factor H-deficient mice. Clin Exp Immunol (2009) 0.84
Familial polyarteritis nodosa. Arthritis Rheum (1994) 0.83
Autoimmune disease and HTLV-1 infection. Br J Rheumatol (1991) 0.83
A study of HLA (Bg) on red cells and platelets by immunoblotting with monoclonal antibodies. Transfusion (1990) 0.83
Intact B cell tolerance in the absence of the first component of the classical complement pathway. Eur J Immunol (2001) 0.83
A lupus-susceptibility C57BL/6 locus on chromosome 3 (Sle18) contributes to autoantibody production in 129 mice. Genes Immun (2008) 0.83
Extrahepatic secreted complement C3 contributes to circulating C3 levels in humans. J Immunol (1996) 0.82
Reduced Susceptibility of Brassica napus to Pratylenchus neglectus in Plants with Elevated Root Levels of 2-Phenylethyl Glucosinolate. J Nematol (1999) 0.81
Factor V Leiden mutation and venous thrombosis. Lancet (1995) 0.81
Murine glomerular mesangial cell uptake of apoptotic cells is inefficient and involves serum-mediated but complement-independent mechanisms. Clin Exp Immunol (2002) 0.81
Vertebral osteomyelitis due to Staphylococcus epidermidis. Br J Rheumatol (1993) 0.81
Complement C1q and C8beta deficiency in an individual with recurrent bacterial meningitis and adult-onset systemic lupus erythematosus-like illness. Rheumatology (Oxford) (2008) 0.80
HLA class I (Bg) antigens on red cells of SLE patients: a serological study with polyclonal and monoclonal antibodies. Vox Sang (1989) 0.80
[Symmetric multiple lipomatosis with Charcot's joint and neuropathic ulcer. Description of a clinical case]. Minerva Med (1993) 0.80
Long-term management after splenectomy. Consider prophylaxis in systematic lupus erythematosus. BMJ (1994) 0.80
Cyclosporin in Behçet's disease: results in 16 patients after 24 months of therapy. Clin Rheumatol (1994) 0.80
Complement components and their autoantibodies. Mol Biotechnol (2003) 0.79
Takayasu's arteritis: a cause of prolonged arterial stiffness. Rheumatology (Oxford) (2006) 0.79
Fergusobia/Fergusonina-induced Shoot Bud Gall Development on Melaleuca quinquenervia. J Nematol (2001) 0.78
Systemic lupus erythematosus and acute demyelinating polyneuropathy. Br J Rheumatol (1994) 0.78
Infection and SLE. Ann Rheum Dis (2002) 0.78
Cloning of the mouse homolog of the 126-kDa human C1q/MBL/SP-A receptor, C1qR(p). Mamm Genome (1999) 0.78
The anti-lipid A antibody HA-1A binds to rough gram-negative bacteria, fixes complement and facilitates binding to erythrocyte CR1 (CD35). Clin Exp Immunol (1993) 0.77
IgG subclass distribution of antibodies against beta(2)-GP1 and cardiolipin in patients with systemic lupus erythematosus and primary antiphospholipid syndrome, and their clinical associations. Rheumatology (Oxford) (2001) 0.77
Complement. Baillieres Clin Haematol (1991) 0.76
Application of age estimation methods based on teeth eruption: how easy is Olze method to use? Int J Legal Med (2014) 0.76
De novo Cryoglobulinaemic Mononeuritis Multiplex during Treatment of Chronic Hepatitis C Infection: A Viral Effect or Induced by Pegylated Interferon Alpha? Case Rep Gastroenterol (2012) 0.76
The anti-lipid A monoclonal antibody E5 binds to rough gram-negative bacteria, fixes C3, and facilitates binding of bacterial immune complexes to both erythrocytes and monocytes. Immunology (1995) 0.75